Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS.

Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, Colville S, Heverin M, Mays I, Pal S, Pender N, Pinto-Grau M, Radakovic R, Shaw CE, Stephenson L, Swingler R, Vajda A, Al-Chalabi A, Hardiman O, Abrahams S.

Neurology. 2018 Oct 9;91(15):e1370-e1380. doi: 10.1212/WNL.0000000000006317. Epub 2018 Sep 12.

2.

Pre-post effectiveness evaluation of Chronic Disease Self-Management Program (CDSMP) participation on health, well-being and health service utilization.

Hevey D, Wilson O'Raghallaigh J, O'Doherty V, Lonergan K; Marese Heffernan; Victoria Lunt; SineadMulhern; Damien Lowry; Niamh Larkin; Kathy McSharry; David Evans; Jackie Morris Roe; Mike Kelly; Peter Pardoe, Harry Ward; Sean Kinsella.

Chronic Illn. 2018 Aug 8:1742395318792063. doi: 10.1177/1742395318792063. [Epub ahead of print]

PMID:
30089405
3.

Longitudinal predictors of caregiver burden in amyotrophic lateral sclerosis: a population-based cohort of patient-caregiver dyads.

Burke T, Hardiman O, Pinto-Grau M, Lonergan K, Heverin M, Tobin K, Staines A, Galvin M, Pender N.

J Neurol. 2018 Apr;265(4):793-808. doi: 10.1007/s00415-018-8770-6. Epub 2018 Feb 2.

PMID:
29396678
4.

Vaccinations not covered under Section 7a: who pays?

Junghans C, Lonergan K, Heffernan C, Gibson K.

Br J Gen Pract. 2018 Feb;68(667):92-93. doi: 10.3399/bjgp18X694781. No abstract available.

PMID:
29371314
5.

Clinical outcomes of suprascapular nerve decompression: a systematic review.

Momaya AM, Kwapisz A, Choate WS, Kissenberth MJ, Tolan SJ, Lonergan KT, Hawkins RJ, Tokish JM.

J Shoulder Elbow Surg. 2018 Jan;27(1):172-180. doi: 10.1016/j.jse.2017.09.025. Review.

PMID:
29221575
6.

Measuring reliable change in cognition using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS).

Crockford C, Newton J, Lonergan K, Madden C, Mays I, O'Sullivan M, Costello E, Pinto-Grau M, Vajda A, Heverin M, Pender N, Al-Chalabi A, Hardiman O, Abrahams S.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):65-73. doi: 10.1080/21678421.2017.1407794. Epub 2017 Dec 7.

PMID:
29214872
7.

The incidence and effect of fatty atrophy, positive tangent sign, and rotator cuff tears on outcomes after total shoulder arthroplasty.

Choate WS, Shanley E, Washburn R, Tolan SJ, Salim TI, Tadlock J, Shealy EC, Long CD, Crawford AE, Kissenberth MJ, Lonergan KT, Hawkins RJ, Tokish JM.

J Shoulder Elbow Surg. 2017 Dec;26(12):2110-2116. doi: 10.1016/j.jse.2017.05.022. Epub 2017 Jul 24.

PMID:
28751092
8.

Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer.

Becker-Santos DD, Lonergan KM, Gronostajski RM, Lam WL.

EBioMedicine. 2017 Aug;22:2-9. doi: 10.1016/j.ebiom.2017.05.027. Epub 2017 May 27. Review.

9.

A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: subphenotypes, staging, cognitive predictors, and survival.

Burke T, Pinto-Grau M, Lonergan K, Bede P, O'Sullivan M, Heverin M, Vajda A, McLaughlin RL, Pender N, Hardiman O.

Ann Clin Transl Neurol. 2017 Apr 11;4(5):305-317. doi: 10.1002/acn3.407. eCollection 2017 May.

10.

Liposomal bupivacaine versus indwelling interscalene nerve block for postoperative pain control in shoulder arthroplasty: a prospective randomized controlled trial.

Abildgaard JT, Lonergan KT, Tolan SJ, Kissenberth MJ, Hawkins RJ, Washburn R 3rd, Adams KJ, Long CD, Shealy EC, Motley JR, Tokish JM.

J Shoulder Elbow Surg. 2017 Jul;26(7):1175-1181. doi: 10.1016/j.jse.2017.03.012. Epub 2017 May 4.

PMID:
28479257
11.

Caregivers of patients with amyotrophic lateral sclerosis: investigating quality of life, caregiver burden, service engagement, and patient survival.

Burke T, Galvin M, Pinto-Grau M, Lonergan K, Madden C, Mays I, Carney S, Hardiman O, Pender N.

J Neurol. 2017 May;264(5):898-904. doi: 10.1007/s00415-017-8448-5. Epub 2017 Mar 9.

PMID:
28280986
12.

Resilience correlates with outcomes after total shoulder arthroplasty.

Tokish JM, Kissenberth MJ, Tolan SJ, Salim TI, Tadlock J, Kellam T, Long CD, Crawford A, Lonergan KT, Hawkins RJ, Shanley E.

J Shoulder Elbow Surg. 2017 May;26(5):752-756. doi: 10.1016/j.jse.2016.12.070. Epub 2017 Feb 10.

PMID:
28190668
13.

Visual encoding, consolidation, and retrieval in amyotrophic lateral sclerosis: executive function as a mediator, and predictor of performance.

Burke T, Lonergan K, Pinto-Grau M, Elamin M, Bede P, Madden C, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 May;18(3-4):193-201. doi: 10.1080/21678421.2016.1272615. Epub 2017 Jan 13.

PMID:
28084080
14.

Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.

Pinto-Grau M, Burke T, Lonergan K, McHugh C, Mays I, Madden C, Vajda A, Heverin M, Elamin M, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):99-106. doi: 10.1080/21678421.2016.1249887. Epub 2016 Nov 28.

PMID:
27894201
15.

Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural Inventory (BBI).

Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O'Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, Hardiman O.

Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):68-73. doi: 10.1080/21678421.2016.1248976. Epub 2016 Nov 28.

PMID:
27894191
16.

Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study.

Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, Pender N.

PLoS One. 2016 Aug 24;11(8):e0160850. doi: 10.1371/journal.pone.0160850. eCollection 2016.

17.

Sex-related Differences in Emergency Department Renal Colic Management: Females Have Fewer Computed Tomography Scans but Similar Outcomes.

Innes GD, Scheuermeyer FX, Law MR, McRae AD, Weber BA, Boyda HN, Lonergan K, Andruchow JE.

Acad Emerg Med. 2016 Oct;23(10):1153-1160. doi: 10.1111/acem.13041.

18.

Discordant performance on the 'Reading the Mind in the Eyes' Test, based on disease onset in amyotrophic lateral sclerosis.

Burke T, Elamin M, Bede P, Pinto-Grau M, Lonergan K, Hardiman O, Pender N.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):467-472. Epub 2016 May 6.

PMID:
27152765
19.

Computerized physician order entry and decision support improves ED analgesic ordering for renal colic.

Netherton SJ, Lonergan K, Wang D, McRae A, Lang E.

Am J Emerg Med. 2014 Sep;32(9):958-61. doi: 10.1016/j.ajem.2014.05.002. Epub 2014 May 12.

PMID:
24997107
20.

DNA methylation is globally disrupted and associated with expression changes in chronic obstructive pulmonary disease small airways.

Vucic EA, Chari R, Thu KL, Wilson IM, Cotton AM, Kennett JY, Zhang M, Lonergan KM, Steiling K, Brown CJ, McWilliams A, Ohtani K, Lenburg ME, Sin DD, Spira A, Macaulay CE, Lam S, Lam WL.

Am J Respir Cell Mol Biol. 2014 May;50(5):912-22. doi: 10.1165/rcmb.2013-0304OC.

21.

Evaluating the effectiveness of a multifaceted, multilevel continuous quality improvement program in primary health care: developing a realist theory of change.

Schierhout G, Hains J, Si D, Kennedy C, Cox R, Kwedza R, O'Donoghue L, Fittock M, Brands J, Lonergan K, Dowden M, Bailie R.

Implement Sci. 2013 Oct 8;8:119. doi: 10.1186/1748-5908-8-119.

22.

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk.

Wilson IM, Vucic EA, Enfield KS, Thu KL, Zhang YA, Chari R, Lockwood WW, Radulovich N, Starczynowski DT, Banáth JP, Zhang M, Pusic A, Fuller M, Lonergan KM, Rowbotham D, Yee J, English JC, Buys TP, Selamat SA, Laird-Offringa IA, Liu P, Anderson M, You M, Tsao MS, Brown CJ, Bennewith KL, MacAulay CE, Karsan A, Gazdar AF, Lam S, Lam WL.

Oncogene. 2014 Sep 4;33(36):4464-73. doi: 10.1038/onc.2013.396. Epub 2013 Oct 7.

23.

Preparedness of orthopaedic surgeons for modern battlefield surgery.

Kearney SP, Bluman EM, Lonergan KT, Arrington ED, Ficke JR.

Mil Med. 2012 Sep;177(9):1058-64.

PMID:
23025135
24.

Human cancer long non-coding RNA transcriptomes.

Gibb EA, Vucic EA, Enfield KS, Stewart GL, Lonergan KM, Kennett JY, Becker-Santos DD, MacAulay CE, Lam S, Brown CJ, Lam WL.

PLoS One. 2011;6(10):e25915. doi: 10.1371/journal.pone.0025915. Epub 2011 Oct 3.

25.

Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions.

Gibb EA, Enfield KS, Stewart GL, Lonergan KM, Chari R, Ng RT, Zhang L, MacAulay CE, Rosin MP, Lam WL.

Oral Oncol. 2011 Nov;47(11):1055-61. doi: 10.1016/j.oraloncology.2011.07.008. Epub 2011 Aug 10.

PMID:
21835683
26.

Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing.

DeFaria Yeh D, Lonergan KL, Fu D, Yeh RW, Echt DS, Foster E.

Europace. 2011 Dec;13(12):1760-5. doi: 10.1093/europace/eur199. Epub 2011 Jul 27.

PMID:
21798878
27.

A sequence-based approach to identify reference genes for gene expression analysis.

Chari R, Lonergan KM, Pikor LA, Coe BP, Zhu CQ, Chan TH, MacAulay CE, Tsao MS, Lam S, Ng RT, Lam WL.

BMC Med Genomics. 2010 Aug 3;3:32. doi: 10.1186/1755-8794-3-32.

28.

Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Lonergan KM, Chari R, Coe BP, Wilson IM, Tsao MS, Ng RT, Macaulay C, Lam S, Lam WL.

PLoS One. 2010 Feb 11;5(2):e9162. doi: 10.1371/journal.pone.0009162.

29.

Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.

Chari R, Thu KL, Wilson IM, Lockwood WW, Lonergan KM, Coe BP, Malloff CA, Gazdar AF, Lam S, Garnis C, MacAulay CE, Alvarez CE, Lam WL.

Cancer Metastasis Rev. 2010 Mar;29(1):73-93. doi: 10.1007/s10555-010-9199-2. Review.

30.

Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.

Shadeo A, Chari R, Lonergan KM, Pusic A, Miller D, Ehlen T, Van Niekerk D, Matisic J, Richards-Kortum R, Follen M, Guillaud M, Lam WL, MacAulay C.

BMC Genomics. 2008 Feb 4;9:64. doi: 10.1186/1471-2164-9-64.

31.

Comparison of the split stacked versus the split achilles allograft for dual femoral tunnel posterior cruciate ligament reconstruction.

DeBerardino TM, Lonergan KT, Brooks DE.

Am J Sports Med. 2008 Jan;36(1):142-8. Epub 2007 Sep 14.

PMID:
17873155
32.

Effect of active smoking on the human bronchial epithelium transcriptome.

Chari R, Lonergan KM, Ng RT, MacAulay C, Lam WL, Lam S.

BMC Genomics. 2007 Aug 29;8:297.

33.

Comprehensive serial analysis of gene expression of the cervical transcriptome.

Shadeo A, Chari R, Vatcher G, Campbell J, Lonergan KM, Matisic J, van Niekerk D, Ehlen T, Miller D, Follen M, Lam WL, MacAulay C.

BMC Genomics. 2007 Jun 1;8:142.

34.

Identification of novel lung genes in bronchial epithelium by serial analysis of gene expression.

Lonergan KM, Chari R, Deleeuw RJ, Shadeo A, Chi B, Tsao MS, Jones S, Marra M, Ling V, Ng R, Macaulay C, Lam S, Lam WL.

Am J Respir Cell Mol Biol. 2006 Dec;35(6):651-61. Epub 2006 Jun 29.

PMID:
16809635
35.

Tobramycin-impregnated calcium sulfate prevents infection in contaminated wounds.

Thomas DB, Brooks DE, Bice TG, DeJong ES, Lonergan KT, Wenke JC.

Clin Orthop Relat Res. 2005 Dec;441:366-71.

PMID:
16331028
36.

Serial analysis of gene expression profiles of developmental stages in non-small cell lung carcinoma.

MacAulay C, Lonergan K, Chi B, Zuyderduyn S, Shein J, Tsao M, LeRiche J, Jones S, Marra M, Lam S, Lam WL.

Chest. 2004 May;125(5 Suppl):97S. No abstract available.

PMID:
15136435
37.

Functions of the von Hippel-Lindau tumour suppressor protein.

Kaelin WG, Iliopoulos O, Lonergan KM, Ohh M.

J Intern Med. 1998 Jun;243(6):535-9. Review.

38.

The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix.

Ohh M, Yauch RL, Lonergan KM, Whaley JM, Stemmer-Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr, Iliopoulos O.

Mol Cell. 1998 Jun;1(7):959-68.

39.

The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal.

Pause A, Lee S, Lonergan KM, Klausner RD.

Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):993-8.

40.

Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin WG Jr.

Mol Cell Biol. 1998 Feb;18(2):732-41.

42.

Evolutionary transfer of ORF-containing group I introns between different subcellular compartments (chloroplast and mitochondrion).

Turmel M, Côté V, Otis C, Mercier JP, Gray MW, Lonergan KM, Lemieux C.

Mol Biol Evol. 1995 Jul;12(4):533-45.

PMID:
7659010
43.
45.

Predicted editing of additional transfer RNAs in Acanthamoeba castellanii mitochondria.

Lonergan KM, Gray MW.

Nucleic Acids Res. 1993 Sep 11;21(18):4402. No abstract available.

46.

Editing of transfer RNAs in Acanthamoeba castellanii mitochondria.

Lonergan KM, Gray MW.

Science. 1993 Feb 5;259(5096):812-6.

PMID:
8430334
47.
48.

Hepatic estrogen receptors and plasma estrogen-binding activity in the Atlantic salmon.

Lazier CB, Lonergan K, Mommsen TP.

Gen Comp Endocrinol. 1985 Feb;57(2):234-45.

PMID:
3979805
49.

Rhythms of cell proliferation in the hindlimb epidermis of control and thyroxine-treated Rana pipiens tadpoles.

Wright ML, Goldrick DM, Adamowicz LJ, Hensen NK, Van Wagoner JL, Lonergan KM.

Gen Comp Endocrinol. 1984 Feb;53(2):272-80.

PMID:
6607861
50.

The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors.

Lazier CB, Richman J, Lonergan K.

Breast Cancer Res Treat. 1984;4(1):19-26.

PMID:
6697008

Supplemental Content

Loading ...
Support Center